These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33469749)

  • 1. Letter to the Editor in Response to Khazanchi et al.
    Nayak A; Islam SJ; Mehta A; Quyyumi AA
    J Gen Intern Med; 2021 Apr; 36(4):1113-1114. PubMed ID: 33469749
    [No Abstract]   [Full Text] [Related]  

  • 2. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].
    Thompson KM; Kalkowska DA; Badizadegan K
    Risk Anal; 2021 Feb; 41(2):389-392. PubMed ID: 33590518
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
    Jayaram A; Buhimschi IA; Buhimschi CS
    Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al.
    Silverman EP; Reddy R; Ataya A; Eagan C
    Respir Med; 2022 Jan; 191():106061. PubMed ID: 35090689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].
    Martins TGDS
    Acta Med Port; 2021 Jan; 34(1):63. PubMed ID: 33092689
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor: Acute Coronary Syndrome Trends and COVID-19 Waves (Response to the Letter of Čulić et al.).
    Sutherland N; Dayawansa N; Filipopoulos B; Vasanthakumar S; Narayan O; Ponnuthurai FA; van Gaal W
    Heart Lung Circ; 2022 Mar; 31(3):e34-e35. PubMed ID: 35033431
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.
    Anderson DA; Godfrey DI
    EBioMedicine; 2022 Mar; 77():103899. PubMed ID: 35278742
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    J Clin Endocrinol Metab; ; . PubMed ID: 34331760
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.